Occupational Asthma and Work- Exacerbated Asthma* Factors Associated With Time to Diagnostic Steps

Size: px
Start display at page:

Download "Occupational Asthma and Work- Exacerbated Asthma* Factors Associated With Time to Diagnostic Steps"

Transcription

1 Original Research ASTHMA Occupational Asthma and Work- Exacerbated Asthma* Factors Associated With Time to Diagnostic Steps Marlene S. Santos, MD; Hyejung Jung, MSc; Javad Peyrovi, MD; Wendy Lou, PhD; Gary M. Liss, MD; and Susan M. Tarlo, MBBS, FCCP Background: Little is known regarding the factors associated with the times for patients first physician visit, the first physician suspicion of work-related asthma (WRA), and final diagnosis after the onset of WRA symptoms. This study examined individual and work-related factors that are associated with longer times to these diagnostic milestones among groups with occupational asthma (OA) and work-exacerbated asthma (WEA). Method: Suspected WRA cases were identified from an occupational lung disease clinic and claimants to the Ontario Workplace Safety and Insurance Board (100 patients each). Questionnaire administration and chart review were undertaken. Results: Eighty participants were classified as having sensitizer-induced OA and 87 as having WEA. For the OA group, the risk factors for delay included male sex, being unmarried, low education, and lack of awareness of association of symptoms with work. Other factors included older age, being the sole income earner, and lack of knowledge of the Workplace Hazardous Materials Information System program. For WEA, lower household income, lower education, absence of a health-and-safety program at work, absence of a union, and lack of awareness of OA and of agents at work that could affect asthma significantly increased the time to diagnostic milestones. Conclusions: Different factors affect the diagnostic milestones for OA and WEA. Findings suggest a need for educational programs for workers who are at risk of OA and WEA and a need for further primary care physician education on WRA. (CHEST 2007; 131: ) Key words: asthma; diagnosis; occupational asthma; socioeconomic factors; work-exacerbated asthma; workplace; workrelated asthma Abbreviations: MSDS material safety data sheet; OA occupational asthma; OR odds ratio; WEA work-exacerbated asthma; WHMIS Workplace Hazardous Materials Information System; WRA work-related asthma; WSIB Workplace Safety and Insurance Board Approximately 13% of the Canadian adult population has been reported to have asthma, and, based on the answers to a questionnaire, 36% of *From the Gage Occupational and Environmental Health Unit (Drs. Santos, Liss, and Tarlo), Toronto, ON, Canada; University of Toronto (Ms. Jung and Dr. Lou), Toronto, ON, Canada; and Toronto Western Hospital (Dr. Peyrovi), Toronto, ON, Canada. Presented in part at the 2005 American Thoracic Society Meeting, San Diego, May Funded by a research grant provided by the Research Advisory Council of the Workplace Safety and Insurance Board (Ontario). Dr. Tarlo has provided consultation to the Ontario Workplace Safety and Insurance Board (WSIB) and has assessed Ontario WSIB claimants at the request of the Ontario WSIB. The WSIB Research Advisory Council is an independent committee awarding research funds for the Ontario WSIB; this is not thought by the author to be those with adult-onset asthma had possible or probable occupational asthma. 1 Asthma caused by exposure to an agent specific to a workplace and not to a conflict of interest. Drs. Santos, Peyrovi, Lou, and Liss, and Ms. Jung have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. Manuscript received October 10, 2006; revision accepted February 12, Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( org/misc/reprints.shtml). Correspondence to: Susan M. Tarlo, MBBS, FCCP, Gage Occupational and Environmental Health Unit, University of Toronto, 223 College St, Toronto, ON, Canada M5T 1R4; susan.tarlo@utoronto.ca DOI: /chest Original Research

2 stimuli outside the work environment, is termed occupational asthma (OA), 2,3 more strictly distinguishing it from coincidental/concurrent asthma that is aggravated or exacerbated at work, referred to as work-exacerbated asthma (WEA) or work-aggravated asthma. Work-related asthma (WRA) is a term including both OA and WEA. WEA is relatively common, accounting for approximately 50% of accepted WRA compensation claims in Ontario. 4 WEA claims are associated with a relatively short period of time missed from work, 5 and, unlike patients with OA, patients with WEA can often return to their usual workplace with adjustments to reduce exposures to likely airway irritants and/or with optimized asthma medication. A minority of OA cases is due to a large exposure to a respiratory irritant. The clearest example of this was the initial description of reactive airways dysfunction syndrome, 6 but broader criteria for irritantinduced asthma have also been used. 7 More commonly ( 90% in a compensation claim population 4 ), OA is caused by sensitization to a specific work chemical or allergen. 4 The outcome of sensitizerinduced OA improves with early diagnosis and removal from further exposure to the suspected sensitizers Delayed diagnosis, more severe asthma at diagnosis, and prolonged exposure to the workplace agent after the onset of symptoms are associated with persisting asthma and morbidity, including hospitalizations. 12 In Ontario, the average time to the medical diagnosis of OA among workers with compensated Workplace Safety and Insurance Board (WSIB) claims was 2 to 3 years after the onset of symptoms. 4 A pilot study 13 has suggested a link between the average time to medical diagnosis and delays associated with worker/patient-related factors, workplace factors, physician/health-care factors, and compensation factors. To our knowledge, no other studies to date have addressed this in patients with WRA. Therefore, we aimed to identify individual and workplace factors relating to the longer time to diagnosis of OA and WEA. Materials and Methods The Research Ethics Board, the University Health Network, and the University of Toronto provided study approval. Patients with suspected WRA from a occupational lung disease clinic of a teaching hospital, with clinical visits from 2002 to 2004, and additional Ontario WSIB claimants from the same time period completed a questionnaire, which was slightly modified from that used in our pilot study. 13 The questionnaire included age, education level, self-perception of work conditions, and physician factors related to diagnosis. It was administered during the study period by a research assistant to those attending the clinic, just before a clinic visit, and by telephone for the additional WSIB claimants. File extraction included dates and outcomes of physician visits, diagnostic investigations, and exposure agents. Definitions The term sensitizer-induced OA refers to asthma that started during the patient s working life, with symptoms improving on weekends or holidays off work, pulmonary function evidence of asthma (ie, at least 12% postbronchodilator improvement in FEV 1, or a provocative concentration of methacholine causing a 20% fall in FEV 1 8 mg/ml), and exposure to a known or presumed work sensitizer. Subcategories included the following: definite OA, including at least one positive work-related test result, work-related changes on serial peak flow readings, at least a threefold improvement in the provocative concentration of methacholine causing a 20% fall in FEV 1 during a period away from work vs during a work period, a positive skin test response to a relevant sensitizer or positive specific challenge response to a workplace sensitizer, and the absence of conflicting findings; probable OA, including a positive work-related test result but also negative response to another test (eg, positive serial peak flow findings but no significant improvement in methacholine response); and possible OA, a negative result for one objective work-related test, but other tests were not performed or had not been performed by the time of the review. The term WEA refers to physician-diagnosed asthma, in which symptoms are worse at work, and in which there is workplace exposure to respiratory irritants such as dusts, smoke, fumes, or sprays. Excluded from analyses were the following: unrelated asthma (ie, two or more work-related test results were negative); and irritant-induced asthma (based on criteria reported by Brooks et al 6 or modified 5,7 ). Statistical Analysis The outcomes of the analyses (ie, diagnostic milestones) were the time from the onset of work-attributed asthma symptoms to the time of (1) the first physician visit (for OA and WEA), (2) the first physician suspicion of WRA (for OA and WEA), and (3) the final diagnosis (for OA). Personal and workplace variables were examined as possible predictors of outcomes. Data analysis was performed using a statistical software package (SAS, version 9; SAS Institute; Cary, NC). Comparisons between OA and WEA groups for the demographic characteristics, individual and workplace factors, and diagnostic tests were assessed using the t test and the 2 test, or, when appropriate, the Wilcoxon test and the Fisher exact test. In univariate analyses, relationships between each response variable and each explanatory variable were examined with the 2 test for binary variables and with logistic regression analysis for continuous variables. Associations of outcomes with covariates were investigated controlling for age and gender. Since the distributions of the time period durations were skewed, we dichotomized them at the median and considered which predictors were associated with a longer duration (greater than median) [additional details are provided in supplemental material on the Web]. Analyses were repeated with subgroups of those patients with probable or definite OA and in WEA subjects who had been assessed by a specialist (results not shown due to similar trends). Results From 200 participants, 100 were recruited from among 102 consecutive eligible patients in the occuwww.chestjournal.org CHEST / 131 / 6/ JUNE,

3 pational lung disease clinic, and 100 others from consecutive Ontario WSIB asthma claimants. Eighty participants (40%; 60 clinic patients and 20 WSIB claimants) were classified as having sensitizer-induced OA, as follows: definite sensitizer-induced OA, 23 participants; probable sensitizer-induced OA, 26 participants; and possible sensitizer-induced OA, 31 participants, The most common agents to which sensitizer-induced OA was attributed were diisocyanates (38% of OA cases). The 87 participants (44%) in the WEA group comprised 14 clinic patients and 73 WSIB claimants. Participants with irritant-induced asthma (n 4) and no WRA (n 29) were excluded from the analyses. As shown in Table 1, those with OA, vs WEA, were more likely to be men (p ) and to have a primary language other than French or English (p 0.001). There was a greater likelihood of having never smoked in those patients with WEA. More OA patients had used Workplace Hazardous Materials Information System (WHMIS) material safety data sheets (MSDSs) and had reported a workplace screening program (31%), as expected with an occupational sensitizer, but a minority of patients had reported undergoing spirometry and responding to screening questionnaires in the workplace. Only 54% of WEA patients had received an assessment from a specialist (ie, pulmonary physician, allergist, or occupational medicine physician) for work-related symptoms at some time compared to all patients with OA (Table 2). The type of physician who was first consulted among 185 patients in the entire group who responded to the question on duration from symptom onset to first physician visit was a family doctor (64%), a company doctor (6%), and a physician in an emergency department or a walk-in clinic (30%). The self-reported median time to the initial physician visit for the patients with WRA symptoms was significantly shorter in patients with WEA ( 1 month) vs those with OA (3 months; p ). Most patients saw a doctor only when symptoms became worse or unbearable (Table 2); a minority of patients were referred by workplace screening. Only a third of patients with OA had prior knowledge of exposure to a work agent that could cause asthma, but most of these patients said it influenced their decision to see a doctor. Most patients with OA reported that coworkers had similar symptoms, and about a third of these patents were influenced by this. A similar proportion reported being influenced by a workplace health-and-safety program. More patients with WEA than with OA recognized symptoms as being work-related (p 0.02), whereas more patients with OA than with WEA feared a diagnosis would lead to job change (p ). More WEA patients had gone to an emergency department or a walk-in clinic initially, whereas most Table 1 Demographic Characteristics of Those With OA and WEA* Demographics and Other Characteristics OA Group (n 80) WEA Group (n 87) OR (95% CI) p Value Clinic patient 60 (75) 14 (16) 0.06 ( ) Age, yr ( ) 0.15 Male gender 47 (59) 26 (30) 0.30 ( ) Unmarried 20 (25) 28 (34) 1.53 ( ) 0.22 Income level $30,000/yr 17 (22) 18 (21) 0.96 ( ) 0.92 Sole source of family income 29 (36) 34 (40) 0.87 ( ) 0.66 Primary language English or French 62 (81) 84 (97) 0.15 ( ) Secondary education and above 71 (90) 82 (94) 0.54 ( ) 0.29 Smoking status Ever smoked 44 (55) 34 (39) 1.91 ( ) 0.04 Current smoker 11 (24) 10 (29) 0.78 ( ) 0.62 Health and safety program 69 (86) 79 (91) 0.64 ( ) 0.35 Health and safety training 48 (61) 52 (65) 0.83 ( ) 0.58 Union 46 (58) 72 (83) 0.29 ( ) Know what WHMIS/MSDS are 72 (90) 78 (90) 1.04 ( ) 0.94 WHMIS/MSDS available 60 (83) 72 (92) 0.42 ( ) 0.09 If yes, ever used them 51 (71) 42 (54) 2.08 ( ) 0.03 Workplace screening 24 (31) 10 (11) 3.42 ( ) Included questionnaire 15 (63) 3 (43) 2.22 ( ) 0.41 Included PFTs 19 (79) 9 (90) 0.42 ( ) 0.64 Diisocyanates at work 30 (38) 1 (1) 0.02 ( ) *Values are given as No. (% of those answering the question) or mean SD, unless otherwise indicated. PFT pulmonary function test; CI confidence interval. Prediagnosis (in Canadian dollars) Original Research

4 Table 2 Individual and Workplace Factors Influencing First Physician Visit and First Physician Suspicion of WRA Among OA and WEA Patients* Variables OA Group (n 80) WEA Group (n 87) OR (95% CI) p Value Symptoms got worse or unbearable 74 (93) 81 (93) 0.91 ( ) 0.88 Workplace screening program 24 (31) 10 (11) 3.42 ( ) Referred through program 7 (29) 4 (36) 0.72 ( ) 0.71 Aware of exposure to an agent at work 26 (33) 51 (59) 0.33 ( ) Influenced by this 23 (88) 39 (75) 2.56 ( ) 0.17 Health and safety program at work influenced visit 24 (36) 14 (19) 2.49 ( ) 0.02 Coworkers with similar symptoms 58 (73) 49 (56) 2.04 ( ) 0.03 Influenced visit 20 (35) 15 (30) 1.26 ( ) 0.58 Knowledge of OA before diagnosis 12 (15) 31 (36) 0.32 ( ) Influenced visit 10 (77) 27 (84) 0.62 ( ) 0.67 Afraid of job change 64 (80) 42 (48) 4.29 ( ) Thought symptoms were work-related 52 (66) 71 (82) 0.43 ( ) 0.02 Physician asked about work association 48 (60) 52 (62) 0.92 ( ) 0.80 Physician first suspected work relation 47 (59) 62 (71) 0.57 ( ) 0.09 Physician told by worker of worsening at work 71 (89) 78 (90) 0.91 ( ) 0.85 Physician referred immediately 42 (53) 22 (26) 3.11 ( ) First physician seen Company doctor 6 (8) 1 (1) Family doctor 56 (73) 46 (56) ED/walk-in clinic 15 (19) 35 (43) Most specialized physician seen Pulmonary physician 75 (96) 35 (44) Allergist 1 (1) 5 (6) Occupational physician 2 (3) 3 (4) Family physician 0 (0) 29 (37) ED physician 0 (0) 7 (9) *Values are given as the No. (% of those answering the question). ED emergency department. See Table 1 for abbreviation not used in the text. OA patients initially saw their family doctor. OA patients were more likely to have had an immediate referral to a specialist when WRA was suspected; almost all OA patients had seen a respiratory physician (Table 2). The reported median time to the first suspicion of WRA by a physician was 1 year for WEA patients and 2 years for OA patients. Both groups reported income loss postdiagnosis, which was more marked among OA patients (p 0.045). As expected, objective tests were more common in OA patients. All patients had a medical history consistent with WRA (by definition). Objective support for asthma was evident in chart review for all OA patients but only for 32% of WEA patients (p ). Test results for the work relationship were present in most OA patients (76%) but only for 11% of WEA patients. The most common tests performed in OA patients were serial peak expiratory flow recordings at work and off work (58%), repeat methacholine challenges during work and off-work periods (49%), and skin tests using a work agent (29%). Only two patients had specific chamber challenges. Factors associated with a longer than median time to the first physician visit after the onset of workrelated symptoms were examined separately among OA and WEA patients (Table 3). Men with WEA were more likely to have a longer than median time to first visit than women (p 0.03). WEA patients were more likely to have a longer time to the first physician visit (adjusted for age and gender) if they feared having to change jobs (p 0.04), lacked awareness of agents at work that could affect their asthma (p 0.04), had no prior knowledge of work and asthma (p 0.002), had no workplace healthand-safety program, health-and-safety training, or union (p 0.003, 0.009, and 0.02, respectively), and had a personal annual income of $30,000 (in Canadian dollars) [p 0.047]. OA subjects were more likely to have a longer time to first physician visit (adjusted for age and gender) if they failed to recognize that symptoms were related to work (p 0.03), were unmarried, (p 0.04), had lived longer in Canada (p 0.001), and had no more than a primary school education (p 0.34). Factors associated with a longer than median time to suspicion of WRA by the physician (as reported by the patient) for OA patients (adjusting for age and gender) [Table 4] were being the sole income earner (p 0.05), not having knowledge of WHMIS CHEST / 131 / 6/ JUNE,

5 Table 3 Bivariate Analysis of Factors Associated With a Longer Than Median Time to First Physician Visit After Onset of Work-Related Symptoms* Variables OA Group (n 71 ) WEA Group (n 85 ) No. (% ) OR (95% CI) No. (% ) OR (95% CI) Time to first physician visit, mo 8 (12.4) (21.2) 1 Clinic patient 26 (48) 2.71 ( ) 8 (67) 0.25 ( ) Male 25 (61) 0.40 ( ) 13 (50) 0.35 ( ) Age, yr 46.5 (10) 1.03 ( ) 44.6 (12) 1.01 ( ) Time in Canada, yr 43 (12) 1.08 ( ) 43 (12.5) 0.97 ( ) Afraid of job loss 20 (44) 0.43 ( ) 14 (44) 2.24 ( ) Afraid of job change 30 (52) 0.82 ( ) 18 (44) 2.76 ( ) Afraid to lose work time 23 (43) 0.26 ( ) 23 (21) 1.39 ( ) Took advice of a friend/family 12 (48) 0.74 ( ) 12 (50) 2.70 ( ) Workplace screening program 7 (41) 0.62 ( ) 2 (20) 0.28 ( ) available Aware exposed to an agent 10 (42) 0.57 ( ) 13 (26) 0.29 ( ) Presence of health and safety 28 (49) 0.88 ( ) 20 (27) 0.02 ( ) program Prior knowledge of OA 3 (27) 0.25 ( ) 3 (10) 0.12 ( ) Symptoms thought work-related 19 (42) 0.27 ( ) 21 (30) 0.43 ( ) Highest education greater than 31 (50) 0.45 ( ) 3 (60) 0.51 ( ) primary Personal income $30,000/yr# 26 (48) 0.39 ( ) 19 (29) 0.31 ( ) Sole income earner 13 (59) 1.54 ( ) 8 (24) 0.46 ( ) First language English or French 34 (60) ( ) 27 (33) 0.35 ( ) Unmarried 12 (71) 0.28 ( ) 7 (26) 1.50 ( ) Presence of health and safety 30 (50) 0.90 ( ) 25 (33) 0.68 ( ) committee Health and safety training 21 (48) 0.69 ( ) 11 (22) 0.23 ( ) Presence of a union 18 (47) 0.77 ( ) 19 (27) 0.23 ( ) Know what WHMIS/MSDS are 35 (55) 5.92 ( ) 25 (33) 0.65 ( ) Distance from specialist 60 km 10 (59) 1.47 ( ) 8 (62) 3.85 ( ) *See Table 1 for abbreviation not used in the text. Number of subjects responding to this outcome variable. Percentage of those answering the question. Values are given as the mean (SD) median. Time units of 1 were assigned a value of 0 in the analyses, p p Values are given as the mean (SD). OR indicates effect per unit. #In Canadian dollars. MSDSs (p 0.06), and older age (p 0.009). For WEA patients, associated factors were as follows: physician not asking about a work association with asthma (p 0.006); lack of knowledge of work and asthma by the worker (p 0.007); travel distance of 60 km to reach a specialist (p 0.08); more dependents (p 0.04); and longer period working (p 0.06). The median time to a final diagnosis of OA after the onset of work-related symptoms was 4 years (Table 5). A longer than median time to a final diagnosis was associated with age (p 0.06). After adjusting for age and gender, a shorter than median time to diagnosis was associated with an awareness of exposure to a work agent causing asthma (p 0.05). Surprisingly, a greater likelihood of a longer time to diagnosis was found in those patients who reported the presence of a workplace screening program (p 0.05). Subgroups of patients with more definite diagnoses (meeting the criteria for definite or probable OA and those with WEA who had been assessed by a specialist) showed trends similar to those of the larger groups (results not shown). Age and gender were important covariates in relationship to the time to the initial visit to a doctor. (Variables with a p value of 0.10 in the multivariate model and potential confounders are demonstrated in the online data supplement; Table E1.) In the final model for OA, age (p 0.04), gender (p 0.01), and personal income (p 0.01) remained associated with the time to the initial visit to a doctor. Years having lived in Canada was highly associated with the outcome (p 0.01; odds ratio [OR], 1.12 [ie, the odds of having a longer time to initial visit to a doctor, greater than median of 3 months, increased approximately 12% with each additional year spent living in Canada]). A workplace screening program had bor Original Research

6 Table 4 Bivariate Analysis of Factors Associated With a Longer Than Median Time to First Physician Suspicion of WRA* Variables OA Group (n 79 ) WEA Group (n 35 ) No. (% ) OR (95% CI) No. (% ) OR (95% CI) Time to first physician suspicion, yr 3.8 (4.3) (7.3) 1 Clinic patient 33 (56) 0.37 ( ) 10 (77) 0.02 ( ) Age, yr 49.5 (8.7) 1.07 ( ) 48.7 (7.5) 1.08 ( ) MD asked about work association 27 (56) 2.33 ( ) 3 (14) 0.06 ( ) Prior knowledge of OA 3 (25) 0.46 ( ) 1 (11) 0.02 ( ) Highest education greater than 32 (46) 0.64 ( ) 11 (33) 0.28 ( ) primary Sole income earner 19 (66) 2.69 ( ) 3 (20) 0.09 ( ) Unmarried 11 (55) 0.72 ( ) 2 (20) 5.23 ( ) Know what WHMIS/MSDS are 32 (45) 0.12 ( ) 11 (35) 0.34 ( ) Distance from specialist 60 km 10 (56) 1.96 ( ) 5 (63) 8.58 ( ) Dependents at symptom onset, No. 1.1 (1.2) 0.84 ( ) 1.6 (1.2) 2.84 ( ) Work-yr 17.2 (9.2) 1.03 ( ) 18.3 (10.6) 1.09 ( ) *See Table 1 for abbreviation not used in the text. Number of subjects responding to this outcome variable. Percentage of those answering the question. Values are given as the mean (SD) median. Time units of 1 were assigned a value of 0 in the analyses, p p Values are given as the mean (SD). OR indicates effect per unit. derline significance (p 0.08). For WEA patients, gender (p 0.04), prior knowledge of WRA (p 0.01), and the presence of a union at the workplace (p 0.05) were significant. Discussion Potential interventions to reduce the time to the diagnosis of WRA include changing regulatory or enforcement policies, better access to compensation, employer education, education of primary treating physicians, and education of pulmonary specialists on the diagnosis and management of WRA. This study extends previous findings 13 by assessing larger groups, including both OA and WEA patients, from populations in clinics and persons who had filed workers compensation claims. Personal and work factors were associated with longer diagnostic milestones. Among those patients with OA, men and those with lower education reported a longer time to first physician visit, perhaps due to greater concerns about the socioeconomic impact. A shorter time to physician assessment and diagnosis was associated with worker knowledge of agents at work that could affect their asthma and the presence of a healthand-safety program, suggesting a benefit from these factors for earlier recognition of WRA. Table 5 Bivariate Analysis of Factors Associated With a Longer Than Median Time to Final Diagnosis of OA From Onset of WRA Symptoms* Variables OA Group (n 77 ) No. (% ) OR (95% CI) Time to final diagnosis, yr 5.0 (4.9) 4 Clinic patient 33 (58) 0.33 ( ) Age, yr 48.3 (9.4) 1.04 ( ) Took advice of friend/family 10 (34) 0.41 ( ) Workplace screening program 16 (67) 2.88 ( ) Aware exposed to an agent 8 (31) 0.35 ( ) Physician visits before suspecting OA, No. 4.6 (8.6) 1.25 ( ) *See Table 1 for abbreviation not used in the text. Number of subjects responding to this outcome variable. Percentage of those answering the question. Values are given as the mean (SD) median. Time units of 1 were assigned a value of 0 in the analyses. Values are given as the mean (SD). OR indicates the effect per unit. p CHEST / 131 / 6/ JUNE,

7 There are several limitations to the interpretation of these data. First, the questionnaire was administered after the diagnosis was reached and is potentially subject to recall bias. As expected, there was a significant difference between the median time to diagnosis of OA and that for WEA (ie, those patients with preexisting asthma should already have had medical follow-up and should have been seen by a physician sooner due to a worsening of their condition), so the potential for inaccurate recollection may be greater among patients in the OA group. The onset of OA may be gradual, and the exact onset date may be difficult to determine. However, the results were assessed separately for each group, and the groups were not directly compared for outcome determinants. OA and WEA groups differed by the source of identification for this study. Those patients with OA were more likely to have a greater amount of information available in their files and to have undergone investigations to confirm the diagnosis, usually requiring specialist referral and reflecting the relative predominance of OA patients from the hospital clinic. In contrast, WEA patients were likely to have received their diagnosis from a primary care physician based on symptoms, 4 and their short time to first physician visit was consistent with an acute exacerbation. 5 Although WEA subjects were most often identified through the Ontario WSIB and OA was most often diagnosed in a hospital-based clinic, OA patients also had WSIB claims. All subjects were clearly informed that the research study would not influence their compensation claim, minimizing the likelihood that responses varied with identification source. The proportions of OA/WEA, although similar to that previously found by us among WSIBaccepted asthma claims, 4 did not necessarily reflect the proportion of WEA among current WSIB-accepted claims since we aimed to enroll similar numbers of patients from the clinic and the WSIB. There could be recall bias in the reporting of workplace factors such as surveillance programs and safety training. However, within each group of OA or WEA patients, there would not be expected to be systematic differences in bias for such reporting. As expected, screening programs at work and diisocyanate exposures were reported more often by the OA group (Ontario has mandated medical surveillance for diisocyanates). Only a minority of patients reported that screening included questionnaires and pulmonary function tests, perhaps reflecting diisocyanate exposure in small companies such as autobody repair shops with difficulty complying with medical surveillance. The short median time to first seeing a physician (1 month) for WEA demonstrates opportunities for physicians to intervene early in the course of WEA, to optimize asthma control, to provide education as to possible work relationships, and to reduce exposures at work to respiratory triggers. Even in OA patients, the 3-month median time to first physician visit suggests opportunities for primary care physicians to question patients about work relationships and to intervene relatively early. Although 53% of those patients with OA reported that their physician referred them for testing as soon as the diagnosis was suspected, further primary care physician education might enhance early referral for more rapid diagnostic testing, thus allowing earlier diagnosis and intervention to improve prognosis. There has been a self-identified need for improved physician knowledge of WRA in Ontario both among primary care physicians and pulmonary specialists. 14 Our findings suggest the need for additional studies to identify factors that may prevent the recognition of WRA. Although the diagnosis is likely to be missed in a significant subset of workers, our study included only those persons who had received a diagnosis of WRA. Factors associated with lack of diagnosis could only be examined in communitybased or worker-based studies. Also, our findings may not be generalizable to workers in countries or regions without universal health-care access or with different physician or compensation systems. ACKNOWLEDGMENT: The authors wish to thank Maya Obadia for assistance with extraction of file data. References 1 Johnson AR, Dimich-Ward HD, Manfreda J, et al. Occupational asthma in adults in six Canadian communities. Am J Respir Crit Care Med 2000; 162: Chan-Yeung M, Malo JL, Tarlo SM, et al. Proceedings of the first Jack Pepys Occupational Asthma Symposium. Am J Respir Crit Care Med 2003; 167: Bernstein I, Chan-Yeung M, Malo JL, et al. Asthma in the workplace. 2nd ed. New York, NY: Marcel Dekker, 1999; Tarlo SM, Liss G, Corey P, et al. A workers compensation claim population for occupational asthma: comparison of subgroups. Chest 1995; 107: Chatkin JM, Tarlo SM, Liss G, et al. The outcome of asthma related to workplace irritant exposures: a comparison of irritant-induced asthma and irritant aggravation of asthma. Chest 1999; 116: Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS): persistent asthma syndrome after high level irritant exposures. Chest 1985; 88: Tarlo SM, Broder I. Irritant-induced occupational asthma. Chest 1989; 96: Lozewicz S, Assoufi BK, Hawkins R, et al. Outcome of asthma induced by isocyanates. Br J Dis Chest 1987; 81: Gannon PF, Weir DC, Robertson AS, et al. Health, employment, and financial outcomes in workers with occupational asthma. Br J Ind Med 1993; 50: Lemiere C, Cartier A, Dolovich J, et al. Outcome of specific 1774 Original Research

8 bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med 1996; 154: Gassert TH, Hu H, Kelsey KT, et al. Long-term health and employment outcomes of occupational asthma and their determinants. J Occup Environ Med 1998; 40: Liss GM, Tarlo SM, MacFarlane Y, et al. Hospitalization among workers compensated for occupational asthma. Am J Respir Crit Care Med 2000; 162: Poonai N, Tarlo SM, van Diepen S, et al. Barriers to diagnosis of occupational asthma in Ontario. Can J Public Health 2005; 96: Tabassum S, Tarlo S, Liss G, et al. Practice Patterns and Educational Assessment of Ontario Respirologists (RPs) for Occupational Lung Disease (OLD) [abstract]. Proc Am Thorac Soc 2005; 2:A443 CHEST / 131 / 6/ JUNE,

Work related asthma: a brief review. October 12, 2015 Mike Pysklywec MD MSc CCFP(EM) DOHS FCBOM

Work related asthma: a brief review. October 12, 2015 Mike Pysklywec MD MSc CCFP(EM) DOHS FCBOM Work related asthma: a brief review October 12, 2015 Mike Pysklywec MD MSc CCFP(EM) DOHS FCBOM Work-related asthma Occupational Asthma Work-aggravated Asthma Sensitizer-induced (allergic) Irritant-induced

More information

O ccupational asthma (OA) is the most commonly

O ccupational asthma (OA) is the most commonly 58 ORIGINAL ARTICLE Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures S M Tarlo, G M Liss, K S Yeung... See end of

More information

Asthma is a common condition, often starting or recurring

Asthma is a common condition, often starting or recurring PRACTICE Occupational asthma: an approach to diagnosis and management Susan M. Tarlo, Gary M. Liss Case A 40-year-old woman comes to the family practice clinic for a routine annual visit. She reports a

More information

Comparison of Peak Expiratory Flow Variability Between Workers With Work- Exacerbated Asthma and Occupational Asthma*

Comparison of Peak Expiratory Flow Variability Between Workers With Work- Exacerbated Asthma and Occupational Asthma* CHEST Comparison of Peak Expiratory Flow Variability Between Workers With Work- Exacerbated Asthma and Occupational Asthma* Samah Chiry, MD; André Cartier, MD; Jean-Luc Malo, MD; Susan M. Tarlo, MD, FCCP;

More information

Occupation is an important consideration in the evaluation

Occupation is an important consideration in the evaluation original Article Work-related : A case-based guide Susan M Tarlo MB BS FRCPC 1, André Cartier MD FRCPC FAAAAI 2, Catherine Lemière MD MSc 2 ; on behalf of the Canadian Thoracic Society Asthma Committee

More information

Work-related Asthma. Discussion paper prepared for. The Workplace Safety and Insurance Appeals Tribunal

Work-related Asthma. Discussion paper prepared for. The Workplace Safety and Insurance Appeals Tribunal Discussion paper prepared for The Workplace Safety and Insurance Appeals Tribunal November 1996 References updated January 2002 Revised March 2014 Prepared by: Dr. Susan M. Tarlo, MB BS FRCP(C) Respirologist

More information

SGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life

SGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective

More information

Revised Protocol: Criteria for Designating Substances as. Occupational Asthmagens on the AOEC List of. Exposure Codes

Revised Protocol: Criteria for Designating Substances as. Occupational Asthmagens on the AOEC List of. Exposure Codes Revised Protocol: Criteria for Designating Substances as Occupational Asthmagens on the AOEC List of Exposure Codes Revised September 2008 1 I. Introduction This is a project to evaluate the current AOEC

More information

SUMMARY DECISION NO. 718/98. Asthma.

SUMMARY DECISION NO. 718/98. Asthma. SUMMARY DECISION NO. 718/98 Asthma. The worker started working as a bricklayer in 1974 and as an industrial bricklayer in 1980. He began experiencing respiratory symptoms in 1982. He continued working

More information

Occupational Asthma Management Beyond the Textbooks Paul Cullinan MD, FRCP

Occupational Asthma Management Beyond the Textbooks Paul Cullinan MD, FRCP Occupational Asthma 1 Professor of Occupational and Environmental Medicine Royal Brompton Hospital and Imperial College London LUNGS AT WORK www.lungsatwork.org.uk Premise and plan Good respiratory physicians

More information

Asthma in the workplace

Asthma in the workplace Work-related asthma Session 2105 Definitions, public health surveillance, and workplace medical monitoring Edward Lee Petsonk, M.D. Professor of Medicine i Section of Pulmonary and Critical Care Medicine

More information

Prevention of occupational asthma practical implications for occupational physicians

Prevention of occupational asthma practical implications for occupational physicians IN-DEPTH REVIEW Occupational Medicine 2005;55:588 594 doi:10.1093/occmed/kqi182... Prevention of occupational asthma practical implications for occupational physicians Susan M. Tarlo 1,2,3,4 and Gary M.

More information

The Compensation of Allergic Disease ALLSA Conference, September 2017

The Compensation of Allergic Disease ALLSA Conference, September 2017 The Compensation of Allergic Disease ALLSA Conference, September 2017 Dr Shahieda Adams MBChB MMed (Occ Med) PhD OCCUPATIONAL MEDICINE DIVISION School of Public Health and Family Medicine University of

More information

Prevalence of work-aggravated symptoms in clinically established asthma

Prevalence of work-aggravated symptoms in clinically established asthma Eur Respir J 2003; 22: 305 309 DOI: 10.1183/09031936.03.00100102 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Prevalence of work-aggravated

More information

Asthma Prevalence among New Hampshire Workers, Behavioral Risk Factor Surveillance System,

Asthma Prevalence among New Hampshire Workers, Behavioral Risk Factor Surveillance System, Asthma Prevalence among New Hampshire Workers, Behavioral Risk Factor Surveillance System, 2011-2012 INTRODUCTION More than 17.5 million adults in the United States suffer from asthma. 1 The American Thoracic

More information

Evaluations. Featured Speakers. Work Related Asthma: Recognition and Diagnosis. Disclosure Statements. Thank You to Our Sponsors: June 19, 2014

Evaluations. Featured Speakers. Work Related Asthma: Recognition and Diagnosis. Disclosure Statements. Thank You to Our Sponsors: June 19, 2014 Evaluations Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. Featured Speakers Work Related Asthma: Recognition

More information

ONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS

ONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS R2 (REVISED MANUSCRIPT BLUE 200208-877OC) ONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS Mario Castro, M.D., M.P.H. Nina A. Zimmermann R.N. Sue

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published

More information

Occupational asthma is a disease characterised. Workplace-specific challenges as a contribution to the diagnosis of occupational asthma

Occupational asthma is a disease characterised. Workplace-specific challenges as a contribution to the diagnosis of occupational asthma Eur Respir J 2008; 32: 997 1003 DOI: 10.1183/09031936.00100207 CopyrightßERS Journals Ltd 2008 Workplace-specific challenges as a contribution to the diagnosis of occupational asthma J-P. Rioux, J-L. Malo,

More information

Diagnosis, management and prevention of occupational asthma

Diagnosis, management and prevention of occupational asthma Setting higher standards Diagnosis, management and prevention of occupational asthma Concise guidance to good practice series April 2012 CONCISE GUIDANCE Clinical Medicine 2012, Vol 12, No 2: 156 9 Concise

More information

Final Progress Report

Final Progress Report Final Progress Report Project title: Grant number: CDC/NIOSH 5 R01 OH 03894-03 Date: January 10, 2005 Principal investigator: William E Daniell, MD MPH Affiliation/institution: Associate Professor Department

More information

Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine

Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine 334 Department of Chest Medicine, Hôpital du Sacré-Coeur, Montreal, Canada C Leroyer J-L Malo D Gautrin 3365 Place de Rouen, Trois-Rivières, Canada D Girard Occupamed, Trois-Rivières, Canada J-G Dufour

More information

BOHRF BOHRF. Occupational Asthma. A Guide for Occupational Health Professionals, Safety Professionals and Safety Representatives BOHRF

BOHRF BOHRF. Occupational Asthma. A Guide for Occupational Health Professionals, Safety Professionals and Safety Representatives BOHRF Occupational Asthma A Guide for Occupational Health Professionals, Safety Professionals and Safety Representatives March 2010 British O Occupational Health Research Foundation This leaflet summarises the

More information

OCCUPATIONAL ASTHMA A GUIDE FOR GENERAL PRACTITIONERS AND PRACTICE NURSES

OCCUPATIONAL ASTHMA A GUIDE FOR GENERAL PRACTITIONERS AND PRACTICE NURSES OCCUPATIONAL ASTHMA A GUIDE FOR GENERAL PRACTITIONERS AND PRACTICE NURSES OCCUPATIONAL ASTHMA A guide for general practitioners and practice nurses. Occupational asthma accounts for up to 15% of all adult

More information

Synergy Respiratory Care Dr. Lyle Melenka

Synergy Respiratory Care Dr. Lyle Melenka 1 2 Synergy Respiratory Care Dr. Lyle Melenka Respiratory Care 2 Accredited Pulmonary Function Labs Cardiac Care 2 Accredited Cardiac Exercise Stress Testing labs WoW Wellness of Workers Early Identification

More information

O C C U P A T I O N A L A S T H M A

O C C U P A T I O N A L A S T H M A O C C U P A T I O N A L A S T H M A TABLE OF CONTENTS What exactly is asthma? 1 What can cause asthma? 1 Workers at risk 1 Clinical Histor y 2 Assessing the Work Environment 2 Lung Function Testing 2 Pulmonar

More information

Occupational asthma. Dr Gordon Parker NHS. Consultant / Honorary Lecturer in Occupational Medicine. Lancashire Teaching Hospitals NHS Foundation Trust

Occupational asthma. Dr Gordon Parker NHS. Consultant / Honorary Lecturer in Occupational Medicine. Lancashire Teaching Hospitals NHS Foundation Trust Occupational asthma Dr Gordon Parker Consultant / Honorary Lecturer in Occupational Medicine Lancashire Teaching Hospitals NHS Foundation Trust NHS The good old bad old days Coal workers pneumoconiosis

More information

Environmental and occupational disorders

Environmental and occupational disorders Environmental and occupational disorders Effectiveness of a medical surveillance program for the prevention of occupational asthma caused by platinum salts: A nested case-control study Rolf Merget, MD,

More information

Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma

Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma Eur Respir J 2004; 23: 730 734 DOI: 10.1183/09031936.04.00027304 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2004 European Respiratory Journal ISSN 0903-1936 Effect of peak expiratory

More information

Predictors of obstructive lung disease among seafood processing workers along the West Coast of the Western Cape Province

Predictors of obstructive lung disease among seafood processing workers along the West Coast of the Western Cape Province Predictors of obstructive lung disease among seafood processing workers along the West Coast of the Western Cape Province Adams S 1, Jeebhay MF 1, Lopata AL 2, Bateman ED 3, Smuts M 4, Baatjies R 1, Robins

More information

F orced expiratory volume in 1 second (FEV1) is an

F orced expiratory volume in 1 second (FEV1) is an 751 ASTHMA FEV 1 decline in occupational asthma W Anees, V C Moore, P S Burge... See end of article for authors affiliations... Correspondence to: Dr W Anees, Princess Elizabeth Hospital, Le Vauquiedor,

More information

WORK-RELATED ASTHMA: Michael Pysklywec Sonia Lal

WORK-RELATED ASTHMA: Michael Pysklywec Sonia Lal WORK-RELATED ASTHMA: Michael Pysklywec, MD MSc CCFP(EM) DOHS FCBOM Occupational Health Clinics for Ontario Workers McMaster University, Department of Clinical Epidemiology & Biostatistics Sonia Lal CRSP,

More information

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado

More information

OCCUPATIONAL ASTHMA A GUIDE FOR OCCUPATIONAL PHYSICIANS AND OCCUPATIONAL HEALTH PRACTITIONERS

OCCUPATIONAL ASTHMA A GUIDE FOR OCCUPATIONAL PHYSICIANS AND OCCUPATIONAL HEALTH PRACTITIONERS OCCUPATIONAL ASTHMA A GUIDE FOR OCCUPATIONAL PHYSICIANS AND OCCUPATIONAL HEALTH PRACTITIONERS OCCUPATIONAL ASTHMA A guide for occupational physicians and occupational health practitioners Occupational

More information

Guidelines for the management of work-related asthma

Guidelines for the management of work-related asthma Eur Respir J 2012; 39: 529 545 DOI: 10.1183/09031936.00096111 ERS TASK FORCE REPORT Guidelines for the management of work-related asthma X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger,

More information

Can serial PEF measurements separate occupational asthma from allergic alveolitis?

Can serial PEF measurements separate occupational asthma from allergic alveolitis? Occupational Medicine 2015;65:251 255 doi:10.1093/occmed/kqv013 Can serial PEF measurements separate occupational asthma from allergic alveolitis? P. S. Burge 1, V. C. Moore 1, C. B. S. G. Burge 1, A.

More information

THE ROLE OF INDOOR ALLERGEN SENSITIZATION AND EXPOSURE IN CAUSING MORBIDITY IN WOMEN WITH ASTHMA

THE ROLE OF INDOOR ALLERGEN SENSITIZATION AND EXPOSURE IN CAUSING MORBIDITY IN WOMEN WITH ASTHMA Online Supplement for: THE ROLE OF INDOOR ALLERGEN SENSITIZATION AND EXPOSURE IN CAUSING MORBIDITY IN WOMEN WITH ASTHMA METHODS More Complete Description of Study Subjects This study involves the mothers

More information

Over the last two decades, occupational

Over the last two decades, occupational Original Article A Comparison between Venables Standardized Respiratory Questionnaire and Pre-Shift Spirometry in Screening of Occupational Asthma in a Steel Industry SJ Mirmohammadi, AH Mehrparvar, M

More information

Changing Patterns of Occupational Respiratory Disease. Malcolm Sim

Changing Patterns of Occupational Respiratory Disease. Malcolm Sim Changing Patterns of Occupational Respiratory Disease Malcolm Sim Centre for Occupational and Environmental Health School of Public Health and Preventive Medicine Monash University Table 2. Estimates

More information

Methacholine versus Mannitol Challenge in the Evaluation of Asthma Clinical applications of methacholine and mannitol challenges

Methacholine versus Mannitol Challenge in the Evaluation of Asthma Clinical applications of methacholine and mannitol challenges Methacholine versus Mannitol Challenge in the Evaluation of Asthma Clinical applications of methacholine and mannitol challenges AAAAI San Antonio Tx February 2013 Catherine Lemière MD, MSc Hôpital du

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 21/08I

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 21/08I WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 21/08I BEFORE: J. Noble: Vice-Chair HEARING: January 2, 2008 at Toronto Written DATE OF DECISION: January 10, 2008 NEUTRAL CITATION: 2008 ONWSIAT

More information

Comparison of clinic models for patients with work-related asthma

Comparison of clinic models for patients with work-related asthma Occupational Medicine 2017;67:477 483 Advance Access publication 26 July 2017 doi:10.1093/occmed/kqx100 Comparison of clinic models for patients with work-related asthma J. C. Lipszyc 1,2,3, F. Silverman

More information

NIOSH FIELD STUDIES ON DAMPNESS AND MOLD AND RELATED HEALTH EFFECTS

NIOSH FIELD STUDIES ON DAMPNESS AND MOLD AND RELATED HEALTH EFFECTS NIOSH FIELD STUDIES ON DAMPNESS AND MOLD AND RELATED HEALTH EFFECTS Jean Cox-Ganser, Ph.D. Division of Respiratory Disease Studies The findings and conclusions in this presentation are those of the author

More information

Asthma: diagnosis and monitoring

Asthma: diagnosis and monitoring Asthma: diagnosis and monitoring NICE guideline: short version Draft for second consultation, July 01 This guideline covers assessing, diagnosing and monitoring suspected or confirmed asthma in adults,

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2275/15

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2275/15 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2275/15 BEFORE: S. Netten: Vice-Chair HEARING: October 23, 2015 at Toronto Written DATE OF DECISION: October 29, 2015 NEUTRAL CITATION: 2015

More information

Health Surveillance. Reference Documents

Health Surveillance. Reference Documents Health Surveillance Trevor Smith Consultant Occupational Physician Reference Documents Control of Substances Hazardous to Health Regulations 2002 HSE Guidance Note MS25 Medical Aspects of Occupational

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1154/14

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1154/14 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1154/14 BEFORE: B. Kalvin : Vice-Chair HEARING: May 22, 2014, at Toronto Written DATE OF DECISION: June 16, 2014 NEUTRAL CITATION: 2014 ONWSIAT

More information

E. Prescott + **, P. Lange* +, J. Vestbo**

E. Prescott + **, P. Lange* +, J. Vestbo** Eur Respir J, 1995, 8, 1333 1338 DOI: 10.1183/09031936.95.08081333 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Chronic mucus hypersecretion

More information

Insomnia in workers with delayed recovery from mild traumatic brain injury

Insomnia in workers with delayed recovery from mild traumatic brain injury Insomnia in workers with delayed recovery from mild traumatic brain injury Tatyana Mollayeva, MD, PhD Acquired Brain Injury Lab Faculty of Medicine University of Toronto Disclosures I do not have financial

More information

PAUL K. HENNEBERGER, SCD, CHRISTOPHER D. HOFFMAN, MS, DAVID J. MAGID, MD, ELLA E. LYONS, MS

PAUL K. HENNEBERGER, SCD, CHRISTOPHER D. HOFFMAN, MS, DAVID J. MAGID, MD, ELLA E. LYONS, MS Original Articles Work-related Exacerbation of Asthma PAUL K. HENNEBERGER, SCD, CHRISTOPHER D. HOFFMAN, MS, DAVID J. MAGID, MD, ELLA E. LYONS, MS Adults with asthma who had been enrolled in an HMO for

More information

Meenu Singh, Joseph L. Mathew, Prabhjot Malhi, B.R. Srinivas and Lata Kumar

Meenu Singh, Joseph L. Mathew, Prabhjot Malhi, B.R. Srinivas and Lata Kumar Comparison of Improvement in Quality of Life Score with Objective Parameters of Pulmonary Function in Indian Asthmatic Children Receiving Inhaled Corticosteroid Therapy Meenu Singh, Joseph L. Mathew, Prabhjot

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 755/05

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 755/05 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 755/05 BEFORE: T. Carroll: Vice-Chair W.D. Jago: Member Representative of Employers R.W. Briggs: Member Representative of Workers HEARING: April

More information

Lung cancer is one of the most common and most. Delays in the Diagnosis and Treatment of Lung Cancer*

Lung cancer is one of the most common and most. Delays in the Diagnosis and Treatment of Lung Cancer* Delays in the Diagnosis and Treatment of Lung Cancer* Eija-Riitta Salomaa, MD, PhD; Susanna Sällinen, BM; Heikki Hiekkanen, MSc; and Kari Liippo, MD, PhD Study objectives: This study was undertaken to

More information

Template 1 for summarising studies addressing prognostic questions

Template 1 for summarising studies addressing prognostic questions Template 1 for summarising studies addressing prognostic questions Instructions to fill the table: When no element can be added under one or more heading, include the mention: O Not applicable when an

More information

Work-Related Asthma in Health Care in Ontario

Work-Related Asthma in Health Care in Ontario AMERICAN JOURNAL OF INDUSTRIAL MEDICINE 54:278 284 (2011) Work-Related Asthma in Health Care in Ontario Gary M. Liss, MD, MS, FRCPC, 1,3 Larisa Buyantseva, MD, MS, 1 Carol E. Luce, BSc, 2 Marcos Ribeiro,

More information

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary

More information

Host determinants for the development of allergy in apprentices exposed to laboratory animals

Host determinants for the development of allergy in apprentices exposed to laboratory animals Eur Respir J 2002; 19: 96 103 DOI: 10.1183/09031936.02.00230202 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Host determinants for the

More information

Heidi Mochari-Greenberger, Ph.D., M.P.H., 1 Thomas Mills, M.S., 2 Susan L. Simpson, Ph.D., 2 and Lori Mosca, M.D., M.P.H., Ph.D. 1

Heidi Mochari-Greenberger, Ph.D., M.P.H., 1 Thomas Mills, M.S., 2 Susan L. Simpson, Ph.D., 2 and Lori Mosca, M.D., M.P.H., Ph.D. 1 JOURNAL OF WOMEN S HEALTH Volume 19, Number 7, 2010 ª Mary Ann Liebert, Inc. DOI: 10.1089=jwh.2009.1749 Original Article Knowledge, Preventive Action, and Barriers to Cardiovascular Disease Prevention

More information

THE UNIVERSITY OF WESTERN ONTARIO Department of Epidemiology & Biostatistics. F. Lortie-Monette, MD, MSc, CSPQ, MBA OCCUPATIONAL ASTHMA

THE UNIVERSITY OF WESTERN ONTARIO Department of Epidemiology & Biostatistics. F. Lortie-Monette, MD, MSc, CSPQ, MBA OCCUPATIONAL ASTHMA THE UNIVERSITY OF WESTERN ONTARIO Department of Epidemiology & Biostatistics 2003 F. Lortie-Monette, MD, MSc, CSPQ, MBA OCCUPATIONAL ASTHMA 1 OCCUPATIONAL ASTHMA Occupational Asthma: the most prevalent

More information

Practical Issues in Asthma Management OCCUPATIONAL ASTHMA. Dr. P. Sherwood Burge, Consultant Physician, Birmingham Heartlands Hospital, Birmingham, UK

Practical Issues in Asthma Management OCCUPATIONAL ASTHMA. Dr. P. Sherwood Burge, Consultant Physician, Birmingham Heartlands Hospital, Birmingham, UK Practical Issues in Asthma Management OCCUPATIONAL ASTHMA Dr. P. Sherwood Burge, Consultant Physician, Birmingham Heartlands Hospital, Birmingham, UK Issue number 24, 2000 Practical Issues in Asthma Management

More information

Asthma Management for the Athlete

Asthma Management for the Athlete Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric

More information

CHAPTER 3: METHODOLOGY

CHAPTER 3: METHODOLOGY CHAPTER 3: METHODOLOGY 3.1 Introduction This study is a secondary data analysis of the 1998 South African Demographic and Health Survey (SADHS) data set of women and households. According to the SADHS

More information

Assessment of impairment/disability due to occupational asthma through a multidimensional approach

Assessment of impairment/disability due to occupational asthma through a multidimensional approach Eur Respir J 2007; 29: 889 896 DOI: 10.1183/09031936.00127206 CopyrightßERS Journals Ltd 2007 Assessment of impairment/disability due to occupational asthma through a multidimensional approach M-R. Yacoub,

More information

ERS 2016 Congress Highlights Interstitial Lung Disease (ILD)

ERS 2016 Congress Highlights Interstitial Lung Disease (ILD) ERS 216 Congress Highlights Interstitial Lung Disease (ILD) London, UK September 3 rd 7 th 216 The 26 th European Respiratory Society International Congress, (ERS) the largest respiratory meeting in the

More information

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.

More information

Work-related asthma, Dr Ryan Hoy Alfred Hospital, Melbourne Monash Centre for Occupational and Environmental Health

Work-related asthma, Dr Ryan Hoy Alfred Hospital, Melbourne Monash Centre for Occupational and Environmental Health Work-related asthma, 2016 Alfred Hospital, Melbourne Monash Centre for Occupational and Environmental Health Overview Asthma in the workplace Is it asthma? Work-exacerbated asthma Occupational asthma Diagnosis

More information

Respiratory Symptoms and Pulmonary Function Test among Salon Employees

Respiratory Symptoms and Pulmonary Function Test among Salon Employees Ahmed A. Aljohaney, MBBS, FRCPC* Shahad M. Daali, MBBS** Hanouf A. Al-juaid, MBBS*** Maysaa T. Ageel, MBBS**** Samaher A. Sukker, MBBS***** Faris F. Alhejaili, MBBS, FRCPC****** Objective: To evaluate

More information

WorkSafeBC. Discussion Paper. Compensation for Occupational Asthma and Contact Dermatitis

WorkSafeBC. Discussion Paper. Compensation for Occupational Asthma and Contact Dermatitis Policy and Research Division Mailing Address PO Box 5350 Stn Terminal Vancouver BC V6B 5L5 Location 6951 Westminster Highway Richmond BC Telephone 604 276-5160 Fax 604 279-7599 WorkSafeBC Policy and Research

More information

Anyone who smokes and/or has shortness of breath and sputum production could have COPD

Anyone who smokes and/or has shortness of breath and sputum production could have COPD COPD DIAGNOSIS AND MANAGEMENT CHECKLIST Anyone who smokes and/or has shortness of breath and sputum production could have COPD Confirm Diagnosis Presence and history of symptoms: Shortness of breath Cough

More information

Michael S. Blaiss, MD

Michael S. Blaiss, MD Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine Division of Clinical Immunology and Allergy University of Tennessee Health Science Center Memphis, Tennessee Speaker s Bureau: AstraZeneca,

More information

BIOSTATISTICAL METHODS

BIOSTATISTICAL METHODS BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH PROPENSITY SCORE Confounding Definition: A situation in which the effect or association between an exposure (a predictor or risk factor) and

More information

Occupational History Quality in Patients With Newly Documented, Clinician-Diagnosed Chronic Bronchitis*

Occupational History Quality in Patients With Newly Documented, Clinician-Diagnosed Chronic Bronchitis* Original Research COPD Occupational History Quality in Patients With Newly Documented, Clinician-Diagnosed Chronic Bronchitis* Ware G. Kuscliner, MD, FCCP; Shainy Hegde, MBBS; and Madhuri Agrau;al, BSc,

More information

Evaluation of Asthma Management in Middle EAst North Africa Adult population

Evaluation of Asthma Management in Middle EAst North Africa Adult population STUDY REPORT SUMMARY Evaluation of Asthma Management in Middle EAst North Africa Adult population Descriptive study on the management of asthma in an asthmatic Middle East Africa adult population Background/Rationale:

More information

Danielle M Nash, Dr. Jason A Gilliland, Dr. Susan E Evers, Dr. Piotr Wilk & Dr. M Karen Campbell. JNEB Journal Club November 3, 2014

Danielle M Nash, Dr. Jason A Gilliland, Dr. Susan E Evers, Dr. Piotr Wilk & Dr. M Karen Campbell. JNEB Journal Club November 3, 2014 Danielle M Nash, Dr. Jason A Gilliland, Dr. Susan E Evers, Dr. Piotr Wilk & Dr. M Karen Campbell JNEB Journal Club November 3, 2014 Presentation Overview Background Objective/ Rationale Methods Prenatal

More information

Fever and leucocytosis accompanying asthmatic reactions due to occupational agents: frequency and associated factors

Fever and leucocytosis accompanying asthmatic reactions due to occupational agents: frequency and associated factors Eur Respir J, 1996, 9, 517 523 DOI: 10.1183/09031936.96.09030517 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Fever and leucocytosis accompanying

More information

Workers Comp and the Toxicology Independent Medical Exam (IME) Brent T. Burton, MD, MPH, FACMT, FAACT

Workers Comp and the Toxicology Independent Medical Exam (IME) Brent T. Burton, MD, MPH, FACMT, FAACT Workers Comp and the Toxicology Independent Medical Exam (IME) Brent T. Burton, MD, MPH, FACMT, FAACT WHAT IS AN IME? An IME is a medical exam conducted to determine the cause, extent and medical treatment

More information

Web enrollment and self assessment for NRT: feasibility and quit rates

Web enrollment and self assessment for NRT: feasibility and quit rates Web enrollment and self assessment for NRT: feasibility and quit rates Peter Selby, MBBS Laurie Zawertailo, PhD Sarwar Hussain, MSc Rosa Dragonetti, MSc Tobacco Smoking in Canada Prevalence of Smoking

More information

A GUIDE FOR THE PRIMARY CARE PHYSICIAN IN EVALUATING DIISOCYANATE EXPOSED WORKERS FOR OCCUPATIONAL ASTHMA

A GUIDE FOR THE PRIMARY CARE PHYSICIAN IN EVALUATING DIISOCYANATE EXPOSED WORKERS FOR OCCUPATIONAL ASTHMA A GUIDE FOR THE PRIMARY CARE PHYICIAN IN EVALUATING DIIOCYANATE EXPOED WORKER FOR OCCUPATIONAL ATHMA David I. Bernstein M.D. Professor of Medicine and Environmental Health Division of Immunology and Allergy

More information

TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS

TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS TARGET POPULATION Eligibility Inclusion Criterion Exclusion Criterion RECOMMENDATIONS Recommendation PULMONARY FUNCTION TESTING (SPIROMETRY) Conditional: The Expert Panel that spirometry measurements FEV1,

More information

Optimal Asthma Control Data Specifications

Optimal Asthma Control Data Specifications Optimal Asthma Control Data Specifications Final Version December 2009: Updated for Population Identification April 2010 MNCM Measure Description Methodology Rationale Composite measure of the percentage

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1645/08

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1645/08 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1645/08 BEFORE: V. Marafioti: Vice-Chair HEARING: July 23, 2008 at Toronto Oral Post-hearing activity completed on July 17, 2009 DATE OF DECISION:

More information

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,

More information

PatientLink MyLinks FHIR. Page 1 of 8. HIMSS Interoperability Showcase 2019

PatientLink MyLinks FHIR. Page 1 of 8. HIMSS Interoperability Showcase 2019 Use Case Title: Patient Centered Interoperability Short Description: Leo Simpson is a 42 year old auto body painter with asthma and pre-diabetes. He utilizes a personal health record (PHR) to manage, aggregate,

More information

COPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum

COPD in Korea. Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum COPD in Korea Division of Pulmonary, Allergy and Critical Care Medicine of Hallym University Medical Center Park Yong Bum Mortality Rate 1970-2002, USA JAMA,2005 Global Burden of Disease: COPD WHO & World

More information

Physicians for a Smoke-Free Canada. A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey

Physicians for a Smoke-Free Canada. A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey Fact Sheet Physicians for a Smoke-Free Canada A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey The Canadian Tobacco Use Monitoring Survey is conducted annually

More information

Cross-sectional assessment of workers with repeated exposure to chlorine over a three year period

Cross-sectional assessment of workers with repeated exposure to chlorine over a three year period Eur Respir J, 1995, 8, 2046 2054 DOI: 10.1183/09031936.95.08122046 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Cross-sectional assessment

More information

THE STATE OF ASTHMA IN INDIANA

THE STATE OF ASTHMA IN INDIANA THE STATE OF ASTHMA IN INDIANA ASTHMA PROGRAM OCTOBER 2015 Jack Kinsey, MPH Asthma Epidemiologist Indiana State Department of Health A healthier and safer Indiana Today s Session Will Cover: Data from

More information

Aalborg Universitet. Statistical analysis plan Riis, Allan; Karran, E. L. ; Jørgensen, Anette; Holst, S.; Rolving, N. Publication date: 2017

Aalborg Universitet. Statistical analysis plan Riis, Allan; Karran, E. L. ; Jørgensen, Anette; Holst, S.; Rolving, N. Publication date: 2017 Aalborg Universitet Statistical analysis plan Riis, Allan; Karran, E. L. ; Jørgensen, Anette; Holst, S.; Rolving, N. Publication date: 2017 Document Version Publisher's PDF, also known as Version of record

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL 2004 ONWSIAT 2563 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 2018/03 [1] This appeal was heard in Toronto on October 24, 2003 and October 15, 2004 by a Tribunal Panel consisting of: S.

More information

Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Chronic obstructive pulmonary disease in over 16s: diagnosis and management National Institute for Health and Care Excellence Draft for consultation Chronic obstructive pulmonary disease in over 16s: diagnosis and management [D] Diagnosing COPD and predicting outcomes NICE guideline

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 412/11

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 412/11 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 412/11 BEFORE: S. Martel : Vice-Chair M. P. Trudeau : Member Representative of Employers A. Grande : Member Representative of Workers HEARING:

More information

SUMMARY. Permanent impairment [NEL] (rating schedule) (AMA Guides) (respiratory impairment).

SUMMARY. Permanent impairment [NEL] (rating schedule) (AMA Guides) (respiratory impairment). SUMMARY DECISION NO. 966/00 Permanent impairment [NEL] (rating schedule) (AMA Guides) (respiratory impairment). The Board granted the worker entitlement for pleural plaques resulting from exposure to asbestos.

More information

COPD most commonly refers to chronic bronchitis, Mild and Moderate-to-Severe COPD in Nonsmokers* Distinct Demographic Profiles

COPD most commonly refers to chronic bronchitis, Mild and Moderate-to-Severe COPD in Nonsmokers* Distinct Demographic Profiles Mild and Moderate-to-Severe COPD in Nonsmokers* Distinct Demographic Profiles Carolyn E. Behrendt, PhD Study objective: To investigate the risk of COPD among nonsmokers. Design: Case-control study, logistic

More information

Exposure to Indoor Biomass Fuel Pollutants and Asthma Prevalence in Southeastern Kentucky: Results From the Burden of Lung Disease (BOLD) Study

Exposure to Indoor Biomass Fuel Pollutants and Asthma Prevalence in Southeastern Kentucky: Results From the Burden of Lung Disease (BOLD) Study University of Kentucky From the SelectedWorks of David M. Mannino September, 2010 Exposure to Indoor Biomass Fuel Pollutants and Asthma Prevalence in Southeastern Kentucky: Results From the Burden of Lung

More information

(Asthma) Diagnosis, monitoring and chronic asthma management

(Asthma) Diagnosis, monitoring and chronic asthma management Dubai Standards of Care 2018 (Asthma) Diagnosis, monitoring and chronic asthma management Preface Asthma is one of the most common problem dealt with in daily practice. In Dubai, the management of chronic

More information

Manuscript type: Research letter

Manuscript type: Research letter TITLE PAGE Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups. Authors Currow DC, 1,2,3 Dal Grande E, 4 Ferreira D, 1 Johnson

More information

11/1/2013. Depression affects approximately 350 million people worldwide, and is the leading cause of disability globally (WHO, 2012)

11/1/2013. Depression affects approximately 350 million people worldwide, and is the leading cause of disability globally (WHO, 2012) Depression affects approximately 350 million people worldwide, and is the leading cause of disability globally (WHO, 2012) College of Arts & Sciences Department of Sociology State University Of New York

More information

Bronchial provocation testing. ICOH Mexico David Lee Sherson, Odense. (Paul Cullinan, London)

Bronchial provocation testing. ICOH Mexico David Lee Sherson, Odense. (Paul Cullinan, London) Bronchial provocation testing ICOH Mexico 2012 David Lee Sherson, Odense (Paul Cullinan, London) Outline definitions, concepts and some history indications methods difficulties summary: should every department

More information

Cancer Patients Interest and Preferences for an Inpatient Smoking Cessation Program (SCP)

Cancer Patients Interest and Preferences for an Inpatient Smoking Cessation Program (SCP) Cancer Patients Interest and Preferences for an Inpatient Smoking Cessation Program (SCP) Lawson Eng, Devon Alton, Yuyao Song, Jie Su, Delaram Farzanfar, Rahul Mohan, Olivia Krys, Tom Yoannidis, Robin

More information

Utility of Lung Clearance Index (LCI) as a Noninvasive Marker of Deployment Lung Disease. Silpa Krefft, M.D., M.P.H. September 20, 2016

Utility of Lung Clearance Index (LCI) as a Noninvasive Marker of Deployment Lung Disease. Silpa Krefft, M.D., M.P.H. September 20, 2016 Utility of Lung Clearance Index (LCI) as a Noninvasive Marker of Deployment Lung Disease Silpa Krefft, M.D., M.P.H. September 20, 2016 Disclosures Mountain and Plains Education and Research Center: Pilot

More information